81 related articles for article (PubMed ID: 22734242)
1. [PPARgamma agonists against respiratory syncytial virus infection in vitro study].
Wan CJ; Dong L; Lin J; Chen XF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):480-2. PubMed ID: 22734242
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells.
Arnold R; König W
Virology; 2006 Jul; 350(2):335-46. PubMed ID: 16616290
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
Arnold R; Neumann M; König W
Immunology; 2007 May; 121(1):71-81. PubMed ID: 17425601
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Arnold R; König W
Virology; 2006 Mar; 346(2):427-39. PubMed ID: 16330064
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
9. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
11. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
Wang JJ; Mak OT
Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):104-11. PubMed ID: 21396480
[TBL] [Abstract][Full Text] [Related]
13. Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells.
Kanunfre CC; da Silva Freitas JJ; Pompéia C; Gonçalves de Almeida DC; Cury-Boaventura MF; Verlengia R; Curi R
Int Immunopharmacol; 2004 Sep; 4(9):1171-85. PubMed ID: 15251113
[TBL] [Abstract][Full Text] [Related]
14. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
Kimura H; Li X; Torii K; Okada T; Takahashi N; Fujii H; Ishihara S; Yoshida H
Nephrol Dial Transplant; 2008 Aug; 23(8):2496-503. PubMed ID: 18367541
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
16. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
Lin TN; Cheung WM; Wu JS; Chen JJ; Lin H; Chen JJ; Liou JY; Shyue SK; Wu KK
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):481-7. PubMed ID: 16385084
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Cerbone A; Toaldo C; Laurora S; Briatore F; Pizzimenti S; Dianzani MU; Ferretti C; Barrera G
Free Radic Biol Med; 2007 Jun; 42(11):1661-70. PubMed ID: 17462534
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
19. [Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof].
Li SJ; Shang T; Li SY; Li QL
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):174-8. PubMed ID: 17425848
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2.
Usui S; Suzuki T; Hattori Y; Etoh K; Fujieda H; Nishizuka M; Imagawa M; Nakagawa H; Kohda K; Miyata N
Bioorg Med Chem Lett; 2005 Mar; 15(6):1547-51. PubMed ID: 15745794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
